Suzhou Aijie Biotechnology Co., Ltd., established on 2001-12-24, Business scope includes research and development,Production Class II6840In vitro diagnostic reagents,And sell the products produced by the company.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

AntiCancer, Inc. operates as a biotechnology company. It develops drugs for cancer based on genetic engineering and targeting cancer specific metabolic defects. The company provides Oncobriteâ, a small-animal imaging technology; MetaMouseâ and ANGIOMOUSEâ that are mouse models of human cancer; Histoculture Drug Response Assay, an individualized cancer therapy; Oncase-PEGâ, a recombinant protein that depletes methionine in tumors; stem cells for general regenerative medicine; tumor-targeting bacteria; and Dermatek, a liposome-based hair-follicle targeting technology. It also offers Enzymatic Homocysteine, Enzymatic B6, and Enzymatic cysteine assays.

Edmond Pharma Srl manufactures active pharmaceutical ingredients. It develops patented product, managed from synthesis to Marketing authorization. The firm��s Erdosteine has a clinically supported efficacy in acute respiratory diseases and COPD (Chronic Obstructive Pulmonary Disease). The company was founded in 1970 and is headquartered in Masate, Italy.

Operates as a chronic disease hospital

Axis-Shield Diagnostics Ltd., a subsidiary of Abbott Laboratories, is a British company located in Dundee. The firm develops novel proprietary diagnostic tests.\nThe company says this about itself: Our expertise encompasses the development of novel proprietary diagnostic tests in areas of clinical need and their incorporation onto the menus of the high throughput analysers of our partners, using a variety of assay technologies.

Axis Biochemicals ASA is a Norwegian private company located in Oslo, with subsidiaries in the United States, that makes diagnostic products. The firm was founded by Erling M. H. Sundrehagen. Svein Wilhelm Faye Lien is the CEO, in this role since 1993.

Degussa AG is the world's third largest producer of precious metals. The company operates three divisions; precious metals and banking, which is involved in precious metals trading, production of precious metals and the manufacture of precious metal compounds and products in addition to operating its own bank, 'Degussa Bank', which is a universal bank providing traditional banking services. Chemical products is the second division and is involved in manufacturing fine and special chemicals, rubbers, pigments and chemical catalysts. The third and final division, health and nutrition is involved in manufacturing pharmaceuticals, dental chemicals and fodder additives. The company has subsidiaries in Germany, other European countries, USA, Brazil, Singapore, Japan and South Korea.

METabolic EXplorer is a biochemistry company that develops industrial alternatives to petrochemical processes. It offers chemical manufacturers viable, long-term alternatives based on renewable resources. METabolic EXplorer considers the economic performance of each production process to be a fundamental factor of competitiveness in relation to petrochemical processes. It is continually working to improve the efficiency of microorganisms and to make its technologies more competitive, notably by diversifying the supply of renewable raw materials. The company aims to produce basic chemical compounds that already have a large number of industrial applications essential to everyday life.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Shenzhen Ausa Pharmed Co. Ltd. is a private company headquartered in China. The firm provides drug clinical trail services.

Nutri Co., Ltd. develops, manufactures, and distributes food products for disease treatment. Its products include V CRESC, V CRESC CP 10, V CRESC Jelly, V CRESC Hi-Petit Jelly, Softia, Isotonic jelly and ISOFO jelly. The company was founded in 1963 and is headquartered in Yokkaichi, Japan.

ZEON Corp. engages in the production and sale of synthetic rubbers and specialty plastics. It operates through the following segments: Elastomer Materials Business, Specialty Materials Business, and Others. The Elastomer Materials Business segment includes synthetic rubbers used in automobile tires and conveyer belts; synthetic lattices used in tires and adhesives; and chemical products such as resins and inks. The Specialty Materials Business segment comprises of synthetic aroma chemicals and other industrial chemicals; information and imaging materials; specialty plastics for optical lenses; and medical products. The Others segment consists of paints, butadiene extraction technology, and reaction injection molding (RIM) formulations and products. The company was founded on April 12, 1950 and is headquartered in Tokyo, Japan.

Alfresa Pharma Corp. manufactures and distributes pharmaceutical products, diagnostics, medical devices, and pharmaceutical raw materials. The company was founded on December 24, 1939 and is headquartered in Osaka, Japan.

Sekisui Medical Co., Ltd., part of Sekisui Chemical Co., Ltd., is a company headquartered in Tokyo, Japan, that manufactures and markets in-vitro diagnostic substances and pharmaceutical products. Sekisui Chemical Co., Ltd. acquired Sekisui Medical Co., Ltd. from Daiichi Sankyo Co., Ltd. on October 02, 2006.

Part of Easy Holdings Co., Ltd., Pathway Intermediates Ltd. is a British company located in Shrewsbury involved in prepared feed and feed ingr. for animals/fowls except dogs/cats. It was founded in 2001. Edward Youngman is currently the CEO of the firm.\nThe company says this about itself: Pathway Intermediates, is the global animal nutrition brand, dedicated to research and development. We believe that the future of animal nutrition lies in the elucidation of critical metabolic pathways and the identification of natural products that can modulate these systems. All of our products are the result of pure science, from which we are able to provide the most optimal and reliable solutions for each customer.

Alltech, Inc. operates as a biotechnology company that engages in health and performance of people, animals, and plants through natural nutrition. Its products include Actigen, Bioplex, Nupro, Mycosorb, Optigen, and Synergen. The company was founded by Pearse Lyons and Deirdre Lyons in 1980 and is headquartered in Nicholasville, KY.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.